kyotorphin has been researched along with beta-funaltrexamine in 1 studies
Studies (kyotorphin) | Trials (kyotorphin) | Recent Studies (post-2010) (kyotorphin) | Studies (beta-funaltrexamine) | Trials (beta-funaltrexamine) | Recent Studies (post-2010) (beta-funaltrexamine) |
---|---|---|---|---|---|
168 | 0 | 22 | 542 | 1 | 54 |
Protein | Taxonomy | kyotorphin (IC50) | beta-funaltrexamine (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.082 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.082 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.082 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 1 |
1 other study(ies) available for kyotorphin and beta-funaltrexamine
Article | Year |
---|---|
Antinociceptive effect of L-arginine in diabetic mice.
Topics: Analgesics; Animals; Arginine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endorphins; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nitroarginine; Pain Measurement; Reaction Time | 1994 |